#United States #Providence #REPX #Nabsys #OhmX

Nabsys Unveils RepX™ for Repeat Expansion Analysis Ahead of ASHG 2026

Nabsys 2.0, LLC has recently made headlines with its latest innovation, the RepX™ pipeline, designed specifically for the nuanced analysis of repeat expansions in genomic research. Scheduled to be showcased at the American Society of Human Genetics (ASHG) Annual Meeting in Montréal, Canada, from October 20–24, 2026, this launch is expected to have a significant impact on how researchers approach certain inherited disorders.

What is RepX™?

The RepX™ tool operates through the Nabsys Navigator™ cloud platform and harnesses the capabilities of Electronic Genome Mapping (EGM) data. This distinctive technology enables the investigation of up to 23 disease-related repeat expansion loci with a single analysis run, all while maintaining a lower cost. This is particularly vital for researchers grappling with the complexity of repeat expansions that are linked to various inherited diseases. These expansions can present significant challenges due to the difficulty in characterizing them accurately.

Unpacking the Technology Behind RepX™

At its core, RepX™ leverages data generated by the OhmX™ platform. The analysis allows researchers to examine ultra-long DNA molecules without amplification or ligation. This approach diminishes biases that can arise from traditional methods, thus providing a clearer picture of expansion sizes and repeat instabilities within individual alleles. The implications of this technology could transformationally advance the understanding of genetic disorders caused by repeat expansions.

Broader Applications and Integration

A noteworthy aspect of RepX™ is its compatibility with the OhmX VOLT Whole Genome Kit. Because the same dataset can facilitate genome-wide structural variant analyses, RepX™ offers an integrative solution along with other tools such as SV-Discover™ and SV-Verify™. These tools allow for visualizations and confirmations of structural variants identified by diverse technologies.

Dr. Barrett Bready, the founder and CEO of Nabsys, emphasized the importance of repeat expansion research in understanding how variations occur within alleles. He stated, "RepX pairs those EGM single-molecule insights with the potential for low-cost, multi-locus analysis—advancing our goal of making single-molecule genomics accessible to every lab." This sentiment really encapsulates the vision Nabsys holds for the future of genomics.

Showcasing Innovations at ASHG 2026

During the ASHG 2026 Annual Meeting, Nabsys is set to demonstrate RepX™ along with the Nabsys Navigator™. At Booth #501, researchers and attendees will have the chance to explore the seamless integration of this innovative pipeline into their genomic studies.

Moreover, Nabsys will present five posters covering research that utilizes EGM technology. Among these is a poster titled, "CRISPR/Cas9 Customization of Electronic Genome Mapping Repeat Expansion Assays," presented by Dr. Kasra Tabatabaei, and an esteemed poster that has been awarded the Reviewers' Choice titled, "CRISPR/Cas9 Optimization by Electronic Genome Mapping," presented by Dr. John Thompson.

As the focus on precision medicine escalates, tools like RepX™ pave the way for enhanced genetic analysis capabilities in laboratories worldwide. This not only fosters innovation within the genomic sector but also democratizes access to sophisticated analysis techniques across research landscapes.

Concluding Thoughts

In conclusion, the introduction of RepX™ represents a significant stride towards simplifying and expanding the realm of repeat expansion analysis in genomics. By making powerful EGM technology accessible, Nabsys is not just advancing its own portfolio but is also contributing to a broader movement towards understanding genetic complexities that continue to challenge the medical community. As we approach ASHG 2026, the excitement surrounding RepX™ and its potential to transform genomic research is palpable and inspiring.

For further information, visit Nabsys' website, where the details of their innovative approaches can be explored more comprehensively.